Condensed Statements of Convertible Preferred Stock and Stockholders Equity (Deficit) - USD ($) $ in Thousands	Series A Convertible Preferred Stock Preferred Stock	Series B Convertible Preferred Stock Preferred Stock	Common Stock	Additional Paid-in Capital	Treasury Stock, Common	Accumulated Other Comprehensive Loss	Accumulated Deficit	Total
Stockholders equity, Beginning balance at Dec. 31, 2020	$ 32,373	$ 64,815		$ 66			$ (23,147)	$ (23,081)
Stockholders equity, Beginning balance (in shares) at Dec. 31, 2020	32,450,000	34,043,889	800,679
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted common stock				5				5
Vesting of restricted common stock (in shares)			7,888
Stock-based compensation				223				223
Issuance of initial public offering common stock, net	$ (32,373)	$ (64,815)	$ 2	188,338				188,340
Issuance of initial public offering common stock, net (in shares)	(32,450,000)	(34,043,889)	21,986,053
Unrealized loss on marketable securities								0
Net loss							(10,150)	(10,150)
Stockholders equity, Ending balance at Jun. 30, 2021			$ 2	188,632			(33,297)	155,337
Stockholders equity, Ending balance (in shares) at Jun. 30, 2021			22,794,620
Stockholders equity, Beginning balance at Mar. 31, 2021	$ 32,373	$ 64,815		133			(28,238)	(28,105)
Stockholders equity, Beginning balance (in shares) at Mar. 31, 2021	32,450,000	34,043,889	804,623
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted common stock				3				3
Vesting of restricted common stock (in shares)			3,944
Stock-based compensation				158				158
Issuance of initial public offering common stock, net	$ (32,373)	$ (64,815)	$ 2	188,338				188,340
Issuance of initial public offering common stock, net (in shares)	(32,450,000)	(34,043,889)	21,986,053
Unrealized loss on marketable securities								0
Net loss							(5,059)	(5,059)
Stockholders equity, Ending balance at Jun. 30, 2021			$ 2	188,632			(33,297)	155,337
Stockholders equity, Ending balance (in shares) at Jun. 30, 2021			22,794,620
Stockholders equity, Beginning balance at Dec. 31, 2021			$ 2	195,881			(55,186)	140,697
Stockholders equity, Beginning balance (in shares) at Dec. 31, 2021			23,205,915
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted common stock				4				4
Vesting of restricted common stock (in shares)			7,890
Issuance of common stock upon stock option exercises				19				$ 19
Issuance of common stock upon stock option exercises (in shares)			44,105					44,105
Stock-based compensation				1,464				$ 1,464
Common stock repurchase					$ (25)			(25)
Common stock repurchase (in shares)			31,154
Unrealized loss on marketable securities						$ (275)		(275)
Net loss							(37,201)	(37,201)
Stockholders equity, Ending balance at Jun. 30, 2022			$ 2	197,368	(25)	(275)	(92,387)	104,683
Stockholders equity, Ending balance (in shares) at Jun. 30, 2022			23,289,064
Stockholders equity, Beginning balance at Mar. 31, 2022			$ 2	196,529		(204)	(72,461)	123,866
Stockholders equity, Beginning balance (in shares) at Mar. 31, 2022			23,253,966
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted common stock				2				2
Vesting of restricted common stock (in shares)			3,944
Stock-based compensation				837				837
Common stock repurchase					(25)			(25)
Common stock repurchase (in shares)			31,154
Unrealized loss on marketable securities						(71)		(71)
Net loss							(19,926)	(19,926)
Stockholders equity, Ending balance at Jun. 30, 2022			$ 2	$ 197,368	$ (25)	$ (275)	$ (92,387)	$ 104,683
Stockholders equity, Ending balance (in shares) at Jun. 30, 2022			23,289,064